W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Decision
P/0542/2023: EMA decision of 21 December 2023 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for amlitelimab (EMEA-003233-PIP01-22)